These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 1717296)
1. Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study. Kornhuber J; Bormann J; Hübers M; Rusche K; Riederer P Eur J Pharmacol; 1991 Apr; 206(4):297-300. PubMed ID: 1717296 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo. Parsons CG; Quack G; Bresink I; Baran L; Przegalinski E; Kostowski W; Krzascik P; Hartmann S; Danysz W Neuropharmacology; 1995 Oct; 34(10):1239-58. PubMed ID: 8570022 [TBL] [Abstract][Full Text] [Related]
3. Affinity of 1-aminoadamantanes for the sigma binding site in post-mortem human frontal cortex. Kornhuber J; Schoppmeyer K; Riederer P Neurosci Lett; 1993 Dec; 163(2):129-31. PubMed ID: 8309617 [TBL] [Abstract][Full Text] [Related]
4. Studies on the mechanism of action of the antiparkinsonian drugs memantine and amantadine: no evidence for direct dopaminomimetic or antimuscarinic properties. Jackisch R; Link T; Neufang B; Koch R Arch Int Pharmacodyn Ther; 1992; 320():21-42. PubMed ID: 1284458 [TBL] [Abstract][Full Text] [Related]
5. Comparative patch-clamp studies with freshly dissociated rat hippocampal and striatal neurons on the NMDA receptor antagonistic effects of amantadine and memantine. Parsons CG; Panchenko VA; Pinchenko VO; Tsyndrenko AY; Krishtal OA Eur J Neurosci; 1996 Mar; 8(3):446-54. PubMed ID: 8963435 [TBL] [Abstract][Full Text] [Related]
6. Different binding affinities of NMDA receptor channel blockers in various brain regions--indication of NMDA receptor heterogeneity. Bresink I; Danysz W; Parsons CG; Mutschler E Neuropharmacology; 1995 May; 34(5):533-40. PubMed ID: 7566488 [TBL] [Abstract][Full Text] [Related]
7. Trapping channel block of NMDA-activated responses by amantadine and memantine. Blanpied TA; Boeckman FA; Aizenman E; Johnson JW J Neurophysiol; 1997 Jan; 77(1):309-23. PubMed ID: 9120573 [TBL] [Abstract][Full Text] [Related]
8. Regionally distinct N-methyl-D-aspartate receptors distinguished by quantitative autoradiography of [3H]MK-801 binding in rat brain. Sakurai SY; Penney JB; Young AB J Neurochem; 1993 Apr; 60(4):1344-53. PubMed ID: 8095974 [TBL] [Abstract][Full Text] [Related]
10. Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties. Kornhuber J; Weller M; Schoppmeyer K; Riederer P J Neural Transm Suppl; 1994; 43():91-104. PubMed ID: 7884411 [TBL] [Abstract][Full Text] [Related]
11. Ca2+ inhibits the association of memantine with N-methyl-D-aspartate (NMDA) receptor-gated ion channels. Fujimoto M; Iida H; Homma T; Kimura I; Mori M; Hamana H Biol Pharm Bull; 2008 Sep; 31(9):1813-5. PubMed ID: 18758084 [TBL] [Abstract][Full Text] [Related]
12. [A comparative study of the central H-cholinergic-blocking and NMDA-blocking actions of MK-801, memantin, amantadine, pyrilen and IEM-1754 in experiments on intact rats]. Gmiro VE; Serdiuk SE Eksp Klin Farmakol; 2000; 63(2):16-20. PubMed ID: 10834088 [TBL] [Abstract][Full Text] [Related]
13. Harmaline competitively inhibits [3H]MK-801 binding to the NMDA receptor in rabbit brain. Du W; Aloyo VJ; Harvey JA Brain Res; 1997 Oct; 770(1-2):26-9. PubMed ID: 9372198 [TBL] [Abstract][Full Text] [Related]
14. Novel adamantane derivatives act as blockers of open ligand-gated channels and as anticonvulsants. Antonov SM; Johnson JW; Lukomskaya NY; Potapyeva NN; Gmiro VE; Magazanik LG Mol Pharmacol; 1995 Mar; 47(3):558-67. PubMed ID: 7535380 [TBL] [Abstract][Full Text] [Related]
15. Electrophysiological study, biodistribution in mice, and preliminary PET evaluation in a rhesus monkey of 1-amino-3-[18F]fluoromethyl-5-methyl-adamantane (18F-MEM): a potential radioligand for mapping the NMDA-receptor complex. Samnick S; Ametamey S; Leenders KL; Vontobel P; Quack G; Parsons CG; Neu H; Schubiger PA Nucl Med Biol; 1998 May; 25(4):323-30. PubMed ID: 9639292 [TBL] [Abstract][Full Text] [Related]
16. [Role of magnesium ions on the regulation of NMDA receptor--a pharmacopathology of memantine]. Kato T Clin Calcium; 2004 Aug; 14(8):76-80. PubMed ID: 15577101 [TBL] [Abstract][Full Text] [Related]
17. Postnatal changes in N-methyl-D-aspartate receptor binding and stimulation by glutamate and glycine of [3H]-MK-801 binding in human temporal cortex. Slater P; McConnell SE; D'Souza SW; Barson AJ Br J Pharmacol; 1993 Apr; 108(4):1143-9. PubMed ID: 8097954 [TBL] [Abstract][Full Text] [Related]
18. Two blocking sites of amino-adamantane derivatives in open N-methyl-D-aspartate channels. Sobolevsky A; Koshelev S Biophys J; 1998 Mar; 74(3):1305-19. PubMed ID: 9512028 [TBL] [Abstract][Full Text] [Related]
19. Potentiation by polyamines of an interaction of noncompetitive antagonists at the N-methyl-D-aspartate receptor ionophore complex with phosphatidylserine. Suzuki T; Ogita K; Yoneda Y Neurochem Int; 1993 Nov; 23(5):427-40. PubMed ID: 7902748 [TBL] [Abstract][Full Text] [Related]
20. [Memantine: a therapeutic drug for Alzheimer's disease and the comparison with MK-801]. Kato T Nihon Yakurigaku Zasshi; 2004 Sep; 124(3):145-51. PubMed ID: 15333987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]